Amneal Pharmaceuticals Inc (NASDAQ:AMRX) price on current trading day, rose 1.37% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $7.76.
A look at the stock’s price movement, the level at last check in today’s session was $7.66, moving within a range at $7.48 and $7.84. The beta value (5-Year monthly) was 1.066. Turning to its 52-week performance, $9.48 and $5.81 were the 52-week high and 52-week low respectively. Overall, AMRX moved -5.65% over the past month.
Amneal Pharmaceuticals Inc’s market cap currently stands at around $2.43 billion, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-27.
Turning to the stock’s technical picture we see that short term indicators suggest on average that AMRX is a 50% Sell. On the other hand, the stock is on average a 75% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend AMRX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AMRX’s current price about 5.60% and -3.89% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 52.83, while 7-day volatility ratio is 2.95% and 4.57% in the 30-day chart. Further, Amneal Pharmaceuticals Inc (AMRX) has a beta value of 1.17, and an average true range (ATR) of 0.31. Analysts have given the company’s stock an average 52-week price target of $11, forecast between a low of $11 and high of $11. Looking at the price targets, the low is -41.75% off recent price level in today’s trading while to achieve the yearly target high, it has to move -41.75%. Nonetheless, investors will most likely welcome a -41.75% jump to $11 which is the analysts’ median price.
If we refocus on Amneal Pharmaceuticals Inc (NASDAQ:AMRX), historical trading data shows that trading volumes averaged 1.71 over the past 10 days and 1.81 million over the past 3 months. The company’s latest data on shares outstanding shows there are 309.88 million shares.
The 56.14% of Amneal Pharmaceuticals Inc’s shares are in the hands of company insiders while institutional holders own 36.62% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.89 million on 2025-04-15, giving us a short ratio of 2.5. The data shows that as of 2025-04-15 short interest in Amneal Pharmaceuticals Inc (AMRX) stood at 243.00002000000003 of shares outstanding, with shares short rising to 3.2 million registered in 2025-03-14. Current price change has pushed the stock -1.96% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AMRX stock continues to rise going into the next quarter.
